Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Vraylar price, strengths & recalls

Brand of cariprazine (generic)

Pharmacies pay $1,524.97 for 30 capsules of Vraylar 1.5 mg capsule this week, and from $1,522.89 to $1,525.85 across its 6 priced strengths and forms. It has 1 recall on record, none ongoing. Its official label last changed on August 20, 2026.

Medicare price 2027Brand
Pharmacies pay$1,524.97for 30 capsules of 1.5 mg capsuleNo change in 4 weeks
Fair cash price
$1,764.22
Strengths
6
Makers
1
Updated
Nov 11

Vraylar price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.5 mg capsule Brand$50.77$1,523.03 / 30 capsulesNo change
0.75 mg capsule Brand$50.81$1,524.26 / 30 capsules-0.1%
1.5 mg capsule Brand$50.83$1,524.97 / 30 capsulesNo change+4.7%
3 mg capsule Brand$50.86$1,525.85 / 30 capsulesNo change+4.8%
4.5 mg capsule Brand$50.78$1,523.48 / 30 capsulesNo change+4.7%
6 mg capsule Brand$50.76$1,522.89 / 30 capsulesNo change+4.7%

The lowest cost per capsule is 6 mg capsule at $50.76. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Vraylar vs generic cariprazine

There is no generic version of Vraylar on the market yet. Its last listed patent or exclusivity runs to March 17, 2030 - generics often follow, though court cases and settlements can move the date either way.

GenericCariprazine prices

Medicare negotiated price

$1,376.00$770.00-44%

Medicare negotiated a maximum fair price of $770.00 for a 30-day supply of Vraylar, against a 2024 list price of $1,376.00. It takes effect on January 1, 2027.

What this means for patients

  • The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
  • What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
  • Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
  • If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Every Medicare negotiated price

Supply status: shortages & recalls

No shortage reportedChecked Nov 15, 2026
No ongoing recalls1 recall on record, latest Jun 2, 2021

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for vraylar? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 20, 2026
Version32 of 22
EffectiveDec 18, 2025
Read the label

These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR. VRAYLAR® (cariprazine) capsules, for oral useInitial U.S. Approval: 2015

This drug has a boxed warning

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

Increased Mortality in Elderly Patients with Dementia-Related Psychosis

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1)].

Suicidal Thoughts and Behaviors

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for the emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.2)].

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis. (5.1)

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. (5.2)

Recent major changes (as listed on the label)

Indications and Usage (1) | 12/2025 |

Dosage and Administration (2.2, 2.3, 2.6) | 12/2025 |

Warnings and Precautions, Metabolic Changes (5.7) | 12/2025 |

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA204370 · Abbvie
First approved
September 17, 2015 (11 years ago)
Latest approved change
December 18, 2025
Approved label
PDF, Dec 22, 2025
Generic makers
None on the market
Last patent listed
March 17, 2030
Exclusivity ends
June 18, 2029

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Vraylar questions

How much does vraylar cost without insurance?

Pharmacies pay about $1,524.97 for 30 capsules of vraylar 1.5 mg capsule ($50.83 per capsule). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $1,764.22. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Vraylar?

Yes: cariprazine. Compare cariprazine prices.

Is vraylar in shortage?

No shortage is reported for vraylar right now. We check the national shortage list every day.

Has vraylar been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the vraylar label last change?

The official label was last updated on August 20, 2026 (version 32). See what changed.

Does Medicare have a negotiated price for Vraylar?

Yes: $770.00 for a 30-day supply of Vraylar, from January 1, 2027. What you pay still depends on your plan.

Talk about vraylar

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.